// App-Quantinova.ai

514 : Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients

Researchers

Presenter

  • Surbhi Warrior

Principal Investigators

  • Elizabeth Behrens

  • Joshua Thomas

  • Priya Rajakumar

  • Sefer Gezer

  • Parameswaran Venugopal

  • Shivi Jain

Medical Centers

  • Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, IL

  • Pediatric Hematology & Oncology, Rush University Medical Center, Chicago, IL

  • Rush University Medical Center, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Vasodilation dysfunction

  • Venous thrombosis

  • Deep vein thrombosis

  • Coronavirus disease

  • Pulmonary embolism

  • Stroke

Biomarkers

  • Body mass index

Drug/Treatment

  • Hydroxychloroquine

  • Tocilizumab

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved